Nov. 20 2024
Source Page: Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisNov. 20 2024
Source Page: Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisNov. 20 2024
Source Page: Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerNov. 20 2024
Source Page: Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerNov. 20 2024
Source Page: Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerNov. 20 2024
Source Page: Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerNov. 20 2024
Source Page: Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisNov. 20 2024
Source Page: Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overNov. 19 2024
Source Page: Digital therapy for chronic tic disorders and Tourette syndrome: early value assessmentNov. 19 2024
Source Page: Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment